Health Condition 1: J312- Chronic pharyngitis
Conditions
Interventions
Intervention1: Habb-e-Khardal: 500 mg (two tablets of 250mg) to be taken orally with water twice daily one hour after meals for 14 days.
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex in the age group of 18-60 years. 2. Patients having Sore throat Pharyngeal Inflammation along with any of these Cough Rhinorrhoea Hoarseness Oral ulcers Conjunctivitis
Exclusion criteria
Exclusion criteria: 1. Age below 18 and more than 60. 2. Patient with GERD. 3. Patient having bacterial pharyngitis. 4. Fever more than 100 F 5. Weak debilitating patients 6. Known cases of other clinically significant co-morbid conditions (severe hepatitis, renal, cardiovascular disorders, etc.) that in the opinion of the investigator could affect the efficacy and safety outcome of the study. 7. Patients with laboratory values outside the normal limits or those with values considered abnormal in the opinion of the investigator 8. Known hypersensitivity to study drug or any of its ingredients. 9. Pregnancy and lactation 10. Any Malignancy 11. History of alcohol and drug abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of the study drug will be assessed on the basis Sore throat questionnaireTimepoint: At baseline, 14th day and 21 day of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline and after 14days | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed